Cypherpunk Technologies Inc. (CYPH) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cypherpunk Technologies Inc. (formerly Leap Therapeutics, Inc.) on December 30, 2025. The Company, incorporated in Delaware and listed on The Nasdaq Capital Market under the symbol "CYPH," is reporting a significant corporate event regarding its cryptocurrency holdings.
Key Financial Metrics and Transaction Details
The filing discloses a specific asset acquisition rather than standard operating financial results. Key metrics related to this transaction include:
- Asset Purchased: 56,418.09 Zcash (ZEC).
- Transaction Value: Approximately $29 million.
- Average Purchase Price: $514.02 per ZEC.
- Total Holdings Post-Transaction: 290,062.67 ZEC.
- Cumulative Average Cost Basis: $334.41 per ZEC.
- Market Share: Holdings represent an estimated 1.76% of the total circulating ZEC network supply.
The filing text does not provide clear values for revenue, profit, cash flow, operating margins, debt, or general liquidity positions for the reporting period.
Material Changes
The primary material change is the increase in the Company's Zcash holdings by approximately 24% (from roughly 233,644 ZEC to 290,062.67 ZEC). This acquisition significantly increased the average cost basis of the total portfolio from the prior cumulative average to the new weighted average of $334.41 per ZEC.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future strategy, or specific risk factors beyond the inherent nature of the transaction. The disclosure is made under Item 7.01 (Regulation FD Disclosure) and Item 8.01 (Other Events). The press release associated with this filing is furnished as Exhibit 99.1 and is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the current market price of Zcash (ZEC) to assess the unrealized gain or loss on the total holdings of 290,062.67 ZEC.
- Confirm the source of the approximately $29 million used for this purchase (e.g., cash on hand, debt financing, or equity issuance) by reviewing the Company's most recent 10-K or 10-Q.
- Review the full text of the press release (Exhibit 99.1) for any additional strategic context not included in the 8-K summary.
- Monitor the Company's liquidity position given the significant capital deployment into a single volatile asset class.